Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System
Withdrawn
- Conditions
- Chlamydia Trachomatis
- First Posted Date
- 2011-05-24
- Last Posted Date
- 2013-03-12
- Lead Sponsor
- Gen-Probe, Incorporated
- Registration Number
- NCT01358799
- Locations
- 🇺🇸
Louisianna State University Health Center, New Orleans, Louisiana, United States
🇺🇸University of North Carolina Chapel Hill STD Clinic, Chapel Hill, North Carolina, United States
🇺🇸Planned Parenthood Northeast Ohio, Akron, Ohio, United States
Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result
Not Applicable
Completed
- Conditions
- Prostatic Neoplasms
- Interventions
- Other: PCA3 Assay
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2012-11-12
- Lead Sponsor
- Gen-Probe, Incorporated
- Target Recruit Count
- 507
- Registration Number
- NCT01024959
- Locations
- 🇺🇸
South Florida Medical Research, Aventura, Florida, United States
🇺🇸Florida Urology Specialists, Sarasota, Florida, United States
🇺🇸Regional Urology Specialists, LLC, Shreveport, Louisiana, United States
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System
Phase 3
Completed
- Conditions
- Human Papillomavirus Infection
- Interventions
- Device: APTIMA HPV AssayDevice: FDA-Approved HPV DNA Test
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2017-01-06
- Lead Sponsor
- Gen-Probe, Incorporated
- Target Recruit Count
- 12896
- Registration Number
- NCT00973362
- Locations
- 🇺🇸
Adams Patterson OB-GYN, Memphis, Tennessee, United States
🇺🇸Healthcare Partners of Monterey Park, Los Angeles, California, United States
🇺🇸Community Medical Research of South Florida, Miami, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath